Loading…
5 companies · GEL, thousands · columns ordered by revenue
Only 4 of 5 peers filed FY2024. Switch to FY2023 (5 of 5).
| Line item | Advanced Medical Techno… | Saertashoriso Sameditsi… | Mirko | Hospimed Georgia | Viva Group |
|---|---|---|---|---|---|
| Total Revenue | 50,081 | 39,590 | 29,409 | 29,264 | — |
| Total COGS | -40,354 | -33,071 | -21,106 | -21,252 | — |
| Gross Profit | 9,727 | 6,519 | 8,303 | 8,012 | — |
| Gross Margin | 19.4% | 16.5% | 28.2% | 27.4% | — |
| Total Operating Expenses | -5,428 | -811 | -2,727 | -2,899 | — |
| EBITDA | 4,298 | 5,708 | 5,576 | 5,113 | — |
| EBITDA Margin | 8.6% | 14.4% | 19.0% | 17.5% | — |
| Total D&A | -130 | -2 | -390 | -32 | — |
| EBIT / Operating Income | 4,168 | 5,706 | 5,186 | 5,080 | — |
| Total Interest Income | 103 | — | 243 | 9 | — |
| Total Other Income | -273 | -312 | 710 | -68 | — |
| Profit Before Tax | 3,999 | 5,287 | 6,102 | 4,941 | — |
| Total Income Tax | -396 | 0 | -848 | 0 | — |
| Net Profit / (Loss) | 3,603 | 5,287 | 5,254 | 4,941 | — |
| Net Margin | 7.2% | 13.4% | 17.9% | 16.9% | — |
| Total Interest Expense | — | -107 | -37 | -80 | — |
Not every picked company reports every selected year — FY2024: no filing for Viva Group. Those cells are left blank (no filing), not zero.
| Company | Sector | EBITDA margin · FY 2024 | Percentile | Sector n |
|---|---|---|---|---|
| Mirko | Medical Devices | 19.0% | 69th pct | 39 |
| Hospimed Georgia | Medical Devices | 17.5% | 67th pct | 39 |
| Saertashoriso Sameditsi… | Medical Devices | 14.4% | 59th pct | 39 |
| Advanced Medical Techno… | Medical Devices | 8.6% | 46th pct | 39 |
| Viva Group | Medical Devices | — | no FY data | 39 |
Percentile is within each company's own sector across the whole FY2024 cross-section (1st–100th; higher = larger value). Companies with no sector, or no filing for the year, are not ranked.